What the Research Says
What the Vitamin D Research Actually Shows
Vitamin D deficiency is widespread, and supplementation trials have produced mixed results. Here's what the evidence actually shows — and why the story is more nuanced than the headlines.
A Supplement With Complicated Evidence
Vitamin D has attracted enormous research attention because of epidemiological associations with nearly every health outcome. The problem: observational studies consistently show low vitamin D correlates with poor health, but supplementation RCTs have frequently failed to replicate these associations. Understanding why requires separating deficiency correction from supraphysiological dosing.
What Replicates Strongly
Vitamin D deficiency (serum 25(OH)D <50 nmol/L) is common in northern latitudes and in people with limited sun exposure. Surveys across Europe, North America, and Asia consistently find 40–60% of adults fall below this threshold by end of winter. Risk factors: skin pigmentation (reduces cutaneous synthesis), indoor work, clothing coverage, and obesity (fat-soluble vitamin sequestration). Deficiency is a real condition with clinical consequences.
Correcting severe deficiency improves musculoskeletal function and reduces fall risk in older adults. The strongest evidence for vitamin D supplementation is in people with confirmed deficiency, particularly those over 65. Meta-analyses of RCTs show clear benefits for muscle strength, fall reduction, and bone density in this population. Effects in younger adults with normal baseline levels are much weaker.
The VITAL trial (25,000 participants) found no benefit of supplementation for cancer incidence or cardiovascular events. The largest vitamin D supplementation RCT found no significant effects on primary cancer incidence or cardiovascular disease over 5+ years in adults without deficiency. However, cancer mortality (not incidence) was reduced — a potentially important distinction. This trial clarified that vitamin D doesn't prevent disease in people with adequate baseline levels.
Vitamin D + K2 combination may improve bone metabolism better than vitamin D alone. Vitamin K2 (MK-7 form) directs calcium into bone rather than arteries. Multiple smaller RCTs show this combination improves bone mineral density markers more than vitamin D alone. The mechanism involves osteocalcin carboxylation — a K2-dependent process. This is increasingly incorporated in supplementation protocols.
Mood and seasonal affective disorder benefits are modest and most evident in deficient populations. Meta-analyses on vitamin D and depression show significant effects in trials starting from deficiency; effects in sufficient populations are small and inconsistent. Some SAD studies show benefit, but light therapy has stronger and more consistent evidence for seasonal mood effects.
What the Research Can't Tell You
Optimal serum levels, supplementation doses, and health outcomes vary by individual genotype (VDR polymorphisms affect vitamin D receptor sensitivity), health status, and baseline level. Testing serum 25(OH)D before supplementing is more informative than blind supplementation — and most people supplementing 1,000–2,000 IU/day discover their levels are already sufficient.